UCLA researchers demonstrate that stem cells can be engineered to kill HIV
Innovative strategy could be effective against other chronic viral diseasesBy Enrique Rivero December 07, 2009
Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases.The study, published Dec. 7 in the-peer reviewed online journal PLoS ONE, provides proof-of-principle — that is, a demonstration of feasibility — that human stem cells can be engineered into the equivalent of a genetic vaccine."We have demonstrated in this proof-of-principle study that this type of approach can be used to engineer the human immune system, particularly the T-cell response, to specifically target HIV-infected cells," said lead investigator Scott G. Kitchen, assistant professor of medicine in the division of hematology and oncology at the David Geffen School of Medicine at UCLA and a member of the UCLA AIDS Institute. "These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of viruses that cause chronic disease, or even different types of tumors."
Tuesday, December 08, 2009
A New Way to Attack AIDS?
My Friend, Michael Sugar, pointed me to this article about a possible new AIDS therapy, using stem cells to help the body fight off AIDS and other chronic illnesses.
Listen to us sing! One final show on Thursday, June 22, 2017 at 7pm at The Metropolitan Room.
I keep meaning to bring up another little history lesson that came from watching the B&W games shows on the Game Show Network. When you...
Hal Block, the increasingly irritating panelist on "What's My Line?" was fired last night after the show. Well, back in 1953. ...
When the history of "The Big Voice: God or Merman? is written, there will be one moment that will shine, for us, above all. And it happ...